CLS
Celestica Inc.
CLS's fundamentals are strong: revenue grew 62% and free cash flow grew 65%. At 24x earnings, it's trading above its usual 18x. Analysts expect that strong growth to continue.
CLS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Strong |
CLS's revenue, profitability, cash flow and balance sheet are all currently healthy.
CLS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $115 | -55% |
| Forward | 14x | $254 | — |
| Fair | 17x | $184 | -28% |
| Current | 24x | $254 | — |
| Expensive | 39x | $411 | +62% |
Historical ranges are pointers, not guarantees.
CLS's PE is in its fair range at 24x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
CLS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for CLS, with profitability holding steady.
CLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $18.05 | +71% |
| Q3 2026 | $10.55 | +75% |
| Q2 2026 | $9.60 | +114% |
| Q1 2026 | $8.25 | +138% |
| Q4 2025 | $7.16 | +105% |
| Q3 2025 | $6.03 | +98% |
| Q2 2025 | $4.49 | +53% |
| Q1 2025 | $3.47 | +33% |
| Q4 2024 | $3.50 | +72% |
CLS's earnings per share have climbed steadily: $10.55 over the past year, up 75% from the year before, and higher year over year for 23 quarters in a row.
CLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.8B | +83% |
| Q2 2026 | $4.7B | +62% |
| Q1 2026 | $4B | +53% |
| Q4 2025 | $3.7B | +44% |
| Q3 2025 | $3.2B | +28% |
| Q2 2025 | $2.9B | +21% |
| Q1 2025 | $2.6B | +20% |
| Q4 2024 | $2.5B | +19% |
CLS's revenue has grown year over year for 20 quarters in a row: $5.8B last quarter, up 83% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.9% | -2.3 points |
| Q2 2026 | 9.8% | +0.3 points |
| Q1 2026 | 6.7% | +1.9 points |
| Q4 2025 | 8.6% | +0.9 points |
| Q3 2025 | 10% | +4.7 points |
| Q2 2025 | 9.4% | +3.9 points |
| Q1 2025 | 4.9% | -0.8 points |
| Q4 2024 | 7.7% | +2.1 points |
CLS's operating margin was 7.9% last quarter, down 2.3 points from the same quarter a year ago.
CLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $115.6M | +30% |
| Q2 2026 | $147.1M | +23% |
| Q1 2026 | $126.8M | +35% |
| Q4 2025 | $155.9M | +471% |
| Q3 2025 | $88.9M | -10% |
| Q2 2025 | $119.9M | +91% |
| Q1 2025 | $93.6M | +38% |
| Q4 2024 | $27.3M | -74% |
CLS's free cash flow has been positive every quarter for seven years: $545M over the past year, up 65% from the year before.
CLS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.8% | +5.6M shares |
| 1 year | +5.1% | +5.9M shares |
| 3 years | +1.8% | +2.2M shares |
| 5 years | -2.9% | -3.7M shares |
| Available history | -5.2% | -6.7M shares |
CLS has 122M diluted shares, up 5.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $22.6M |
| Q4 2025 | $35.7M |
| Q3 2025 | — |
| Q2 2025 | $40M |
| Q1 2025 | $77.7M |
| Q4 2024 | $25.5M |
CLS spent $58M buying back its own shares over the past year, down 59% from the year before.
CLS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 0.5x | Very low |
CLS has more cash than debt.
CLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.2 | Neutral |
| Stochastic | 15.5 | Oversold |
CLS's weekly RSI is 42 (neutral) and its Stochastic is 16 (oversold).
CLS PE vs Technology Sector
| Metric | CLS | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 28x | 14% below |
| PE % | 64 | 35 | 29 pts above |
CLS is trading at 24x earnings, a 14% discount to the Technology sector's median of 28x.
CLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $300.6 | 15% below |
| 20 week MA | $313.9 | 19% below |
| 50 week MA | $321.3 | 21% below |
| 100 week MA | $243.1 | 4.5% above |
| 200 week MA | $139.6 | 82% above |
CLS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 82% above its 200-week average.
CLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.11 | $7.71 | -4.9% |
| 2021 | $7.71 | $10.9 | +41% |
| 2022 | $10.9 | $10.9 | -0.2% |
| 2023 | $10.9 | $29.3 | +170% |
| 2024 | $29.3 | $95.1 | +225% |
| 2025 | $95.1 | $303.6 | +219% |
| 2026 YTD | $303.6 | $254.0 | -16% |
CLS has finished higher in four of the last six years, three of them by more than 50%. It's down 16% so far in 2026.